Clinical trial
Neurobiology and Treatment of Reading Disability in NF1
NCT02964884 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurobiology and Treatment of Reading Disability in NF1
- Lead sponsor
- Vanderbilt University
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- November 30, 2016
- Completion date
- January 31, 2027
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
learning disability, neurofibromatosis type 1, nf1, reading disability